July 7, 2022

Positive results from phase III PRIME study of Zejula at Society of Gynecologic Oncology Meeting – Zai Lab + GSK

Zai Lab Limited presented data from the Phase III PRIME study of Zejula (niraparib) as maintenance therapy at the Society of Gynecologic Oncology annual meeting . Zejula demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) with a tolerable safety profile in Chinese patients with newly diagnosed advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (collectively […]

admin Health 0 1 min read
March 17, 2022

Diagnosis and self-help for ovarian cancer

It is a complete myth that ovarian cancer is a silent killer – even early-stage disease causes symptoms and knowing what they are is key to early treatment, according to Dr Sharon Tate, Head of Primary Care Development, Target Ovarian Cancer (TOC). Target Ovarian Cancer works hard to stamp out the myth of ‘the silent killer’, says Dr Tate. In […]

admin Health 0 3 min read
March 16, 2022

Ovarian cancer – facts and symptoms

Two thirds of UK women with ovarian cancer are diagnosed late when the cancer has spread and is difficult to treat.  IMI spoke to Dr Sharon Tate, Head of Primary Care Development, Target Ovarian Cancer (TOC) to find out more. More than 7000 women, mainly over the age of 50 years, are diagnosed with ovarian cancer every year in the […]

admin Health 0 2 min read

Recent Posts

Meta

Categories

Archives

Recent Comments